542 reports of this reaction
1.8% of all MAGNESIUM SULFATE IN WATER FOR reports
#11 most reported adverse reaction
ANAEMIA is the #11 most commonly reported adverse reaction for MAGNESIUM SULFATE IN WATER FOR, manufactured by AVADIM HOLDINGS, INC.. There are 542 FDA adverse event reports linking MAGNESIUM SULFATE IN WATER FOR to ANAEMIA. This represents approximately 1.8% of all 29,923 adverse event reports for this drug.
Patients taking MAGNESIUM SULFATE IN WATER FOR who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is a less commonly reported adverse event for MAGNESIUM SULFATE IN WATER FOR, but still significant enough to appear in the safety profile.
In addition to anaemia, the following adverse reactions have been reported for MAGNESIUM SULFATE IN WATER FOR:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 542 FDA reports for MAGNESIUM SULFATE IN WATER FOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 1.8% of all adverse event reports for MAGNESIUM SULFATE IN WATER FOR, making it a notable side effect.
If you experience anaemia while taking MAGNESIUM SULFATE IN WATER FOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.